Amyotrophic Lateral Sclerosis
Conditions
Brief summary
A tele-health treatment study for individuals with early stage ALS with the aim to improve communication, cough response, and respiratory strength. All participants complete a respiratory strength training program using an Expiratory Muscle Strength Training (EMST 150) device from the comfort of their homes for 6 weeks.
Detailed description
The investigators are looking for people with early stage ALS to participate in a completely tele-health (no in-person visits required) treatment study examining the effects of an Expiratory Muscle Strength Training device (EMST-150) on communication, cough, and respiratory strength. Participants will be required to attend 2 virtual baseline assessment sessions followed by 12 additional virtual training sessions (2 per week for 6 weeks). Participants should plan to be actively enrolled in the study for \ 10 weeks (3 weeks of baseline monitoring followed by 6 weeks of training). Participants will also be required to fill out a series of questionnaires assessing the EMST's effectiveness via tele-health.
Interventions
All participants will forcefully breathe out into an Expiratory Muscle Strength Training device (EMST-150) 25 times per day for 6 weeks. The EMST device will be set at a moderate intensity level (50% of each participant's maximum expiratory pressure).
Sponsors
Study design
Intervention model description
All participants enrolled will receive the intervention.
Eligibility
Inclusion criteria
* Diagnosis of ALS * Within the early stages of disease progression (i.e., able to talk, breathe, and eat independently) * Speaker of English * Have a family member/caregiver willing to assist as needed * Have access to an electronic device and internet for tele-health
Exclusion criteria
* A history of neurological disease (besides ALS) * A history of asthma or respiratory problems (e.g., COPD, emphysema) * A history of head, neck, or chest surgery (except mastectomy) * A history of smoking within the last 5 years * Reliance on mechanical ventilation (including CPAP)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change From Baseline to Post-treatment for Maximum Expiratory Pressure | Baseline 2 (week 2), Pre-Training (week 3), and Post-Training (week 10) | Change in expiratory muscle strength throughout the study duration measured by the participant blowing into a pressure meter |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change From Baseline to Post-Treatment in Utterance Length | Baseline 1 (week 1) and Post-Training (week 10) | Change in utterance length (# of syllables produced on one breath) throughout the study duration. Participant read the Rainbow Passage and data were collected from this task. |
| Change From Baseline to Post-Treatment in Number of Pauses | Baseline 1 (week 1) and Post-Training (week 10) | Change in the total number of pauses that included breathing (breath pauses). Participant read the Rainbow Passage and data were collected from this task. |
| Change From Baseline to Post-Treatment in Syntactic Location of Pauses | Baseline 1 (week 1) and Post-Training (week 10) | Change in the location of pauses while breathing produced while reading. We determined where participants took breaths while reading the Rainbow Passage and categorized them according to syntax. Categories included at a major boundary (at the end of an independent clause marked by a period) and at a boundary that is not related to syntax (not a major or minor syntactical location). The number of pauses at each category of boundaries were converted to a percent of the total breaths taken while reading the passage. |
| Telehealth Satisfaction | Post-Training (week 10) | Participants rated 15 statements with a 5-point Likert scale ranging from strongly disagree (1) to strongly agree (5). Example statements include: I can easily talk to my health-care provider, I can hear my health-care provider clearly, I can see my health-care provider as if we met in person, I think the care provided via telemedicine is consistent, and I receive adequate attention, telemedicine provides for my health care need, and overall, I am satisfied with the quality of service being provided via telemedicine. Total scores range from 0-75 and individual statement scores ranged from 1-5, with higher scores indicating higher satisfaction with the telepractice modality. |
| Change From Pre-Training to Post-Training in Communication Participation Item Bank | Pre-Training (week 3) and Post-Training (week 10) | Participants were instructed to use a 4-point Likert scale (3: not at all; 2: a little; 1: quite a bit; 0: very much) to rate if/how their ALS impacts ten hypothetical communicative situations. Participants total scores were then added together, ranging from 0-30, and converted to a T-score ranging from 24.2-71.0. High scores are more favorable, indicating that the participant feels that ALS impacts their communicative participation less than those with lower scores. |
| Peak Expiratory Flow Rate | Baseline 2 (week 2), Pre-training (week 3), Post-Training (week 10) | Change in cough strength (as measured by peak expiratory flow rate) throughout the study duration, measured using a flow meter that the participant coughs into - single coughs. Data from baseline 2 and pre-training were averaged for the pre--training value. |
| ALS Function Rating Scale Revised | Baseline 1 (week 1) and Post-Training (week 10) | A survey that quantifies change in disease progression throughout the study duration. Participants rate how 12 physical functions are impacted by their ALS. For each function, participants are provided with a 4-point Likert scale to rate whether they still have complete control of that function (4) or no ability to perform that function (0). Total scores range from 0 to 48, with lower scores indicating more severe symptoms and higher scores and less severe symptoms. |
| Psychosocial Impact of Assistive Devices Scale | Post-treatment (week 10) | A survey assessing how the training device/modality impacts patient's psychosocial functions. The PIADS includes 12 items for competence, 6 for adaptability, and 8 for self-esteem. Participants use a 7-point Likert scale to rate the impact of a device on each item: a maximum negative impact (-3), somewhat negative impact (-2 or -1), zero impact (0), somewhat positive impact (1 or 2), maximum positive impact (3). Total scores range from -78 (maximum negative impact) to 78 (maximum positive impact). |
| Tele-health Session Attendance | Measured at the end of training across the entire training period | % of training sessions scheduled and attended by participants throughout the study duration |
| Adherence to Training Protocol | Measured each week of training across the entire training duration | Number of of training exhalations completed (25 exhalations into the device, 5 days per week) by participants throughout the study duration |
| Change From Baseline to Post-Treatment in ALS Quality of Life Scale | Baseline 1 (week 1) and Post-Training (week 10) | The ALS Quality of Life Scale-Revised (ALSQOL-R) (Simmons, 2015) was used to measure how ALS impacts their quality of life in six domains: negative emotion, interaction with people and the environment, intimacy, religiosity, physical symptoms, and bulbar function. Participants rate whether they strongly disagree (0) or strongly agree (10) with 46 statements. Each domain score is given an average value between 0 (worse) and 10 (best). Total scores on the ALSQOL-R range from 0-460, but an average score ranging from 0-10 is computed by dividing the total score by the total number of items completed by the participant (usually 46). Higher scores reflect a higher quality of life. A survey assessing how each participant feels ALS impacts quality of life, and how that changes throughout the study duration. Total scores range from 0-460, with higher scores indicating greater contributions of ALS to quality of life. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Expiratory Muscle Strength Training All participants will forcefully breathe out into an Expiratory Muscle Strength Training device (EMST-150) 25 times per day for 6 weeks. The EMST device will be set at a moderate intensity level (50% of each participant's maximum expiratory pressure).
Expiratory Muscle Strength Training (EMST-150): All participants will forcefully breathe out into an Expiratory Muscle Strength Training device (EMST-150) 25 times per day for 6 weeks. The EMST device will be set at a moderate intensity level (50% of each participant's maximum expiratory pressure). | 13 |
| Total | 13 |
Withdrawals & dropouts
| Period | Reason | FG000 |
|---|---|---|
| Overall Study | Withdrawal by Subject | 1 |
Baseline characteristics
| Characteristic | Expiratory Muscle Strength Training |
|---|---|
| Age, Continuous | 59.46 years STANDARD_DEVIATION 8.63 |
| ALSFRS-R baseline | 38.8 units on a scale STANDARD_DEVIATION 3.75 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 2 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 11 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Montreal Cognitive Assessment baseline | 28.23 units on a scale STANDARD_DEVIATION 1.42 |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) White | 13 Participants |
| Region of Enrollment United States | 13 participants |
| Sex: Female, Male Female | 4 Participants |
| Sex: Female, Male Male | 9 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 13 |
| other Total, other adverse events | 0 / 13 |
| serious Total, serious adverse events | 0 / 13 |
Outcome results
Change From Baseline to Post-treatment for Maximum Expiratory Pressure
Change in expiratory muscle strength throughout the study duration measured by the participant blowing into a pressure meter
Time frame: Baseline 2 (week 2), Pre-Training (week 3), and Post-Training (week 10)
Population: All participants with baseline, pre-training, and post-treatment maximum expiratory pressure values were included. The second baseline and pre-training values were averaged to obtain the pre-training value which was used along with the week 10 value (post-treatment).
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Expiratory Muscle Strength Training | Change From Baseline to Post-treatment for Maximum Expiratory Pressure | Pre-training average | 66.10 cmH2O | Standard Deviation 41.77 |
| Expiratory Muscle Strength Training | Change From Baseline to Post-treatment for Maximum Expiratory Pressure | Post-training (week 10) | 83.75 cmH2O | Standard Deviation 45.99 |
Adherence to Training Protocol
Number of of training exhalations completed (25 exhalations into the device, 5 days per week) by participants throughout the study duration
Time frame: Measured each week of training across the entire training duration
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Expiratory Muscle Strength Training | Adherence to Training Protocol | 90.65 percent of at-home training completed | Standard Deviation 16.94 |
ALS Function Rating Scale Revised
A survey that quantifies change in disease progression throughout the study duration. Participants rate how 12 physical functions are impacted by their ALS. For each function, participants are provided with a 4-point Likert scale to rate whether they still have complete control of that function (4) or no ability to perform that function (0). Total scores range from 0 to 48, with lower scores indicating more severe symptoms and higher scores and less severe symptoms.
Time frame: Baseline 1 (week 1) and Post-Training (week 10)
Population: All participants with baseline (week 1) and post-training (week 10) scores were included.
| Arm | Measure | Group | Value (MEAN) |
|---|---|---|---|
| Expiratory Muscle Strength Training | ALS Function Rating Scale Revised | Baseline (week 1) | 39 score on a scale |
| Expiratory Muscle Strength Training | ALS Function Rating Scale Revised | Post-training (week 10) | 37 score on a scale |
Change From Baseline to Post-Treatment in ALS Quality of Life Scale
The ALS Quality of Life Scale-Revised (ALSQOL-R) (Simmons, 2015) was used to measure how ALS impacts their quality of life in six domains: negative emotion, interaction with people and the environment, intimacy, religiosity, physical symptoms, and bulbar function. Participants rate whether they strongly disagree (0) or strongly agree (10) with 46 statements. Each domain score is given an average value between 0 (worse) and 10 (best). Total scores on the ALSQOL-R range from 0-460, but an average score ranging from 0-10 is computed by dividing the total score by the total number of items completed by the participant (usually 46). Higher scores reflect a higher quality of life. A survey assessing how each participant feels ALS impacts quality of life, and how that changes throughout the study duration. Total scores range from 0-460, with higher scores indicating greater contributions of ALS to quality of life.
Time frame: Baseline 1 (week 1) and Post-Training (week 10)
Population: All participants with pre- and post-training scores on the scale. Lower scores reflect less effect of ALS on quality of life.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Expiratory Muscle Strength Training | Change From Baseline to Post-Treatment in ALS Quality of Life Scale | pre-training | 5.97 units on a scale | Standard Deviation 0.99 |
| Expiratory Muscle Strength Training | Change From Baseline to Post-Treatment in ALS Quality of Life Scale | post-training | 5.94 units on a scale | Standard Deviation 0.94 |
Change From Baseline to Post-Treatment in Number of Pauses
Change in the total number of pauses that included breathing (breath pauses). Participant read the Rainbow Passage and data were collected from this task.
Time frame: Baseline 1 (week 1) and Post-Training (week 10)
Population: All participants with baseline and post-training values. Data from the first baseline and the week 10 post-treatment value were used.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Expiratory Muscle Strength Training | Change From Baseline to Post-Treatment in Number of Pauses | Baseline (reading) - week 1 | 15.89 number of pauses | Standard Deviation 8.28 |
| Expiratory Muscle Strength Training | Change From Baseline to Post-Treatment in Number of Pauses | Post-training (reading) - week 10 | 16.75 number of pauses | Standard Deviation 10.99 |
Change From Baseline to Post-Treatment in Syntactic Location of Pauses
Change in the location of pauses while breathing produced while reading. We determined where participants took breaths while reading the Rainbow Passage and categorized them according to syntax. Categories included at a major boundary (at the end of an independent clause marked by a period) and at a boundary that is not related to syntax (not a major or minor syntactical location). The number of pauses at each category of boundaries were converted to a percent of the total breaths taken while reading the passage.
Time frame: Baseline 1 (week 1) and Post-Training (week 10)
Population: All participants with baseline and post-training values. Data from baseline (week 1) and post-training (week 10) were used.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Expiratory Muscle Strength Training | Change From Baseline to Post-Treatment in Syntactic Location of Pauses | Baseline, boundaries unrelated to syntax | 8.71 percent of pauses at the boundary | Standard Deviation 13.09 |
| Expiratory Muscle Strength Training | Change From Baseline to Post-Treatment in Syntactic Location of Pauses | Baseline, major boundaries | 47.12 percent of pauses at the boundary | Standard Deviation 37.59 |
| Expiratory Muscle Strength Training | Change From Baseline to Post-Treatment in Syntactic Location of Pauses | Post-training, major boundaries | 46.09 percent of pauses at the boundary | Standard Deviation 18.92 |
| Expiratory Muscle Strength Training | Change From Baseline to Post-Treatment in Syntactic Location of Pauses | Post-training, boundaries unrelated to syntax | 12.33 percent of pauses at the boundary | Standard Deviation 17.36 |
Change From Baseline to Post-Treatment in Utterance Length
Change in utterance length (# of syllables produced on one breath) throughout the study duration. Participant read the Rainbow Passage and data were collected from this task.
Time frame: Baseline 1 (week 1) and Post-Training (week 10)
Population: All participants who had baseline and post-training values for this measure. Data from the first baseline and the week 10 post-treatment value were used.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Expiratory Muscle Strength Training | Change From Baseline to Post-Treatment in Utterance Length | Baseline (reading) - week 1 | 10.76 syllables | Standard Deviation 3.29 |
| Expiratory Muscle Strength Training | Change From Baseline to Post-Treatment in Utterance Length | Post-training (reading) - week 10 | 10.39 syllables | Standard Deviation 4.11 |
Change From Pre-Training to Post-Training in Communication Participation Item Bank
Participants were instructed to use a 4-point Likert scale (3: not at all; 2: a little; 1: quite a bit; 0: very much) to rate if/how their ALS impacts ten hypothetical communicative situations. Participants total scores were then added together, ranging from 0-30, and converted to a T-score ranging from 24.2-71.0. High scores are more favorable, indicating that the participant feels that ALS impacts their communicative participation less than those with lower scores.
Time frame: Pre-Training (week 3) and Post-Training (week 10)
Population: All participants with pre- and post-training scores. Data from the pre-training in week 3 and the week 10 post-treatment value were used.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Expiratory Muscle Strength Training | Change From Pre-Training to Post-Training in Communication Participation Item Bank | post-training (week 10) | 48.51 T-score scale points | Standard Deviation 14.65 |
| Expiratory Muscle Strength Training | Change From Pre-Training to Post-Training in Communication Participation Item Bank | pre-training (week 3) | 47.78 T-score scale points | Standard Deviation 15.96 |
Peak Expiratory Flow Rate
Change in cough strength (as measured by peak expiratory flow rate) throughout the study duration, measured using a flow meter that the participant coughs into - single coughs. Data from baseline 2 and pre-training were averaged for the pre--training value.
Time frame: Baseline 2 (week 2), Pre-training (week 3), Post-Training (week 10)
Population: All participants with baseline 2 (week 2) and pre-training values (week 3) and post-training (week 10) data were included.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Expiratory Muscle Strength Training | Peak Expiratory Flow Rate | Post-training (week 10) | 273.47 liters per minute | Standard Deviation 127.69 |
| Expiratory Muscle Strength Training | Peak Expiratory Flow Rate | Pre-training average | 265.97 liters per minute | Standard Deviation 141.47 |
Psychosocial Impact of Assistive Devices Scale
A survey assessing how the training device/modality impacts patient's psychosocial functions. The PIADS includes 12 items for competence, 6 for adaptability, and 8 for self-esteem. Participants use a 7-point Likert scale to rate the impact of a device on each item: a maximum negative impact (-3), somewhat negative impact (-2 or -1), zero impact (0), somewhat positive impact (1 or 2), maximum positive impact (3). Total scores range from -78 (maximum negative impact) to 78 (maximum positive impact).
Time frame: Post-treatment (week 10)
Population: All participants with a post-treatment (week 10) score.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Expiratory Muscle Strength Training | Psychosocial Impact of Assistive Devices Scale | 28.08 score on a scale | Standard Deviation 26.61 |
Telehealth Satisfaction
Participants rated 15 statements with a 5-point Likert scale ranging from strongly disagree (1) to strongly agree (5). Example statements include: I can easily talk to my health-care provider, I can hear my health-care provider clearly, I can see my health-care provider as if we met in person, I think the care provided via telemedicine is consistent, and I receive adequate attention, telemedicine provides for my health care need, and overall, I am satisfied with the quality of service being provided via telemedicine. Total scores range from 0-75 and individual statement scores ranged from 1-5, with higher scores indicating higher satisfaction with the telepractice modality.
Time frame: Post-Training (week 10)
Population: Only assessed at post-training. Included all participants who completed the scale. Higher values reflect more satisfaction and the score maximum is 75.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Expiratory Muscle Strength Training | Telehealth Satisfaction | 60.58 score on a scale | Standard Deviation 7.69 |
Tele-health Session Attendance
% of training sessions scheduled and attended by participants throughout the study duration
Time frame: Measured at the end of training across the entire training period
Population: Participants who completed the training protocol
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Expiratory Muscle Strength Training | Tele-health Session Attendance | 95.37 percentage of sessions attended | Standard Deviation 7.43 |